申请人:Kuethe T. Jeffrey
公开号:US20070015923A1
公开(公告)日:2007-01-18
The present invention is directed to a process for preparing certain hydroisoindoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The compounds are useful in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
本发明涉及一种制备特定羟基异吲哚啉化合物的方法,这些化合物可用作神经激肽-1(NK-1)受体拮抗剂,以及缓释激肽和特别是P物质的抑制剂。这些化合物在治疗某些疾病中很有用,包括呕吐、尿失禁、抑郁症和焦虑症。